J. Légal

Chromosomal aberrations induced by chemotherapy and radiotherapy in lymphocytes from patients with breast carcinoma.

J. Bourhis, N. Chavaudra, F. Eschwège, 2002, International journal of radiation oncology, biology, physics.

Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma.

M. Schlumberger, C. Parmentier, P. Voisin, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radiosensitivity of human normal and tumoral thyroid cells using fluorescence in situ hybridization and clonogenic survival assay.

B. Caillou, A. Laplanche, C. Parmentier, 1999, International journal of radiation oncology, biology, physics.

Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131.

M. Schlumberger, C. Parmentier, R. M’kacher, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Biological dosimetry after total body irradiation (TBI) for hematologic malignancy patients.

F. Eschwège, C. Parmentier, R. M’kacher, 2000, International journal of radiation oncology, biology, physics.

Intrinsic radiosensitivity and chromosome aberration analysis using fluorescence in situ hybridization in cells of two human tumor cell lines.

P. Lambin, A. Begg, C. Parmentier, 1994, Radiation research.

The identification and characterization of a novel human differentiation-inhibiting protein that selectively blocks erythroid differentiation.

R. Tremblay, J. Durkin, J. Whitfield, 1992, Blood.

Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma.

M. Schlumberger, C. Parmentier, B. Aubert, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.